Hyperlipemia Clinical Trial
Official title:
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Efficacy, as Well as Immunogenecity, Pharmacokineticks and Pharmacodynamics of Multiple Doses of JS002 on Stable Statin Therapy in Patients With Hyperlipidemia.
JS002 is a recombinant humanized anti-PCSK9 monoclonal antibody.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04382521 -
A Text Message Intervention to Promote Health Behaviors in Cardiac Risk Conditions
|
N/A | |
| Not yet recruiting |
NCT02593487 -
Effect of Rosuvastatin Therapy on HDL2 Level
|
Phase 4 | |
| Active, not recruiting |
NCT02697422 -
Veteran Peer Coaches Optimizing and Advancing Cardiac Health
|
N/A | |
| Recruiting |
NCT05912296 -
A Single and Multiple Ascending Doses Study to Evaluate the Safety, Tolerability and Pharmacokinetics of RBD7022
|
Phase 1 | |
| Active, not recruiting |
NCT05432544 -
Safety and Tolerability of SHR-1918 in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT03950752 -
Effect of Consumption of Bagel Without Palm Oil on Postprandial Lipidemia
|
N/A | |
| Not yet recruiting |
NCT06229548 -
A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2053
|
Phase 1 | |
| Completed |
NCT05532800 -
The Efficacy and Safety of JS002 PFS and AI in Patients With Primary Hypercholesterolemia and Mixed Hyperlipidemia
|
Phase 3 | |
| Completed |
NCT04781114 -
The Safety and Efficacy of Multiple-dose of JS002 in Subject With Hyperlipidemia
|
Phase 3 | |
| Active, not recruiting |
NCT04515927 -
To Evaluate the Efficacy and Safety of JS002 in HoFH Patients
|
Phase 2 |